NOVARTIS PHARMA AG

NOVARTIS PHARMA AG INDIA COMPANY PROFILE

Novartis Pharma AG in India is primarily a MANUFACTURER. It is not solely a trader.

COMPANY INTRODUCTION

Novartis Pharma AG is a leading global healthcare company, headquartered in Basel, Switzerland. It operates worldwide, including a significant presence in India. The company focuses on discovering, developing, manufacturing, and marketing innovative medicines to improve and extend people's lives. Its portfolio includes a wide range of prescription drugs, generics (through its Sandoz division), and eye care products (through Alcon, which was spun off but historically part of Novartis's broader operations).

In India, Novartis Pharma AG operates as a key pharmaceutical player. Its activities encompass:

Manufacturing: Novartis has manufacturing facilities in India where it produces various pharmaceutical products for both the Indian market and for export. These facilities adhere to global quality standards.

Research and Development: While primary global R&D is centered in Switzerland and the US, Novartis has R&D capabilities and clinical trial operations in India, contributing to its global drug development pipeline.

Sales and Marketing: The company has a robust commercial presence in India, responsible for the sales, marketing, and distribution of its innovative medicines across therapeutic areas such as oncology, cardiovascular, immunology, neuroscience, and respiratory.

Novartis's commitment in India extends beyond business operations to include patient access programs and corporate social responsibility initiatives, aiming to address local healthcare challenges and improve public health.

Novartis Pharma AG in India produces or sells a range of pharmaceutical products across various therapeutic areas. Some of these include:

Cosentyx

Entresto

Gleevec

Lucentis

Xolair

Zolgensma

Promacta/Revolade

Jakavi

Tafinlar + Mekinist

Mayzent

Sandostatin

Exelon

Galvus

Vymada

Signifor

Aimovig